Eversana ValuationCaseStudy
|
6
|
Resverlogix Corp.
|
Jan 03, 2022 11:00PM
|
Expected Market Action - Covid-19 Phase 2
|
3
|
Resverlogix Corp.
|
Feb 04, 2021 04:47PM
|
Extended Betonmace trial
|
5
|
Resverlogix Corp.
|
Apr 20, 2017 05:02PM
|
Fall is Coming
|
3
|
Resverlogix Corp.
|
Sep 06, 2015 11:36AM
|
FDA approval status
|
3
|
Resverlogix Corp.
|
Dec 03, 2015 06:37PM
|
Financial Statements
|
6
|
Resverlogix Corp.
|
Jul 28, 2020 05:21PM
|
Ho Ho and a bottle of rum
|
2
|
Resverlogix Corp.
|
Dec 18, 2016 10:07PM
|
Hopefully DM's exuberance is justified in the secondary endpoints
|
1
|
Zenith Epigenetics
|
Nov 16, 2019 12:18PM
|
I don’t get it
|
3
|
Resverlogix Corp.
|
May 22, 2019 11:20PM
|
iceberg or ice cube?
|
10
|
Resverlogix Corp.
|
May 16, 2017 03:14AM
|
Lets have some fun!
|
2
|
Resverlogix Corp.
|
Dec 15, 2016 01:28PM
|
LIFTOFF!
|
5
|
Resverlogix Corp.
|
Nov 06, 2015 10:09PM
|
Market Cap - 10.5mil
|
5
|
Resverlogix Corp.
|
Jul 24, 2024 01:22PM
|
Merck's Verubecestat mechanisn of Action vs.RVX-208 & ZEN BET Inhibition Mechanism of action
|
2
|
Resverlogix Corp.
|
Jan 23, 2017 04:45PM
|
Nasdaq Listing Soon
|
5
|
Resverlogix Corp.
|
Sep 30, 2015 11:16AM
|
No news
|
1
|
Resverlogix Corp.
|
Sep 15, 2022 10:50AM
|
Notice of 2024 Annual Meeting Delayed?
|
2
|
Resverlogix Corp.
|
May 23, 2024 11:19AM
|
ONT-380
|
1
|
Zenith Epigenetics
|
Feb 04, 2016 11:24AM
|
ONT-380
|
4
|
Resverlogix Corp.
|
Feb 04, 2016 11:25AM
|
Pioneers
|
9
|
Resverlogix Corp.
|
Nov 09, 2015 12:52AM
|